


Ask a doctor about a prescription for SOLIFENACIN NORMON 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Solifenacin Normon 5 mg film-coated tablets EFG
Solifenacin succinate
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
The active substance solifenacin belongs to the group of anticholinergics. These medications are used to reduce the activity of the overactive bladder. This allows you to have more time before needing to go to the bathroom and increases the amount of urine your bladder can hold.
Solifenacin is used to treat the symptoms of overactive bladder syndrome. These symptoms include: having a strong and sudden need to urinate without warning, needing to urinate frequently, or having urine leaks because you cannot reach the bathroom in time.
Do not take Solifenacin Normon
Before starting treatment with solifenacin, inform your doctor if you have or have had any of the above-mentioned diseases.
Warnings and precautions
Consult your doctor or pharmacist before starting to take solifenacin:
Inform your doctor before starting treatment with solifenacin if any of the above circumstances have ever occurred to you.
Before starting treatment with solifenacin, your doctor will assess if there are other causes for your frequent need to urinate (e.g., heart failure (insufficient pumping capacity of the heart) or kidney disease). If you have a urinary tract infection, your doctor will prescribe an antibiotic (treatment against certain bacterial infections).
Children and adolescents
Solifenacin Normon should not be used in children or adolescents under 18 years of age.
Other medications and Solifenacin Normon
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
It is especially important to inform your doctor if you are taking:
Taking Solifenacin Normon with food and drinks
Solifenacin can be taken with or without food, as you prefer.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Do not use solifenacin if you are pregnant, unless it is absolutely necessary.
Do not use solifenacin during breastfeeding, as solifenacin may pass into breast milk.
Driving and using machines
Solifenacin may cause blurred vision and sometimes drowsiness or fatigue. If you experience any of these side effects, do not drive or use machines.
Solifenacin Normon contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the instructions for administration of this medication exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
You should swallow the tablet whole with some liquid. It can be taken with or without food, as you prefer. Do not crush the tablets.
The normal dose is 5 mg per day, unless your doctor tells you to take 10 mg per day.
If you take more Solifenacin Normon than you should
If you have taken too much solifenacin or if a child has accidentally taken solifenacin, contact your doctor or pharmacist immediately, or call the Toxicology Information Service (Tel. 91 562 04 20).
The symptoms in case of overdose may include: headache, dry mouth, dizziness, drowsiness, and blurred vision, perception of things that are not there (hallucinations), pronounced excitement, convulsions, difficulty breathing, increased heart rate (tachycardia), accumulation of urine in the bladder (urinary retention), and dilation of the pupils (mydriasis).
If you forget to take Solifenacin Normon
If you forget to take a dose at the usual time, take it as soon as you remember, unless it is time to take the next dose. Never take more than one dose per day. If you are unsure, consult your doctor or pharmacist.
Do not take a double dose to make up for forgotten doses.
If you stop taking Solifenacin Normon
If you stop taking solifenacin, your overactive bladder symptoms may return or worsen. Always consult your doctor if you are thinking of stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
If you suffer an allergic reaction or a severe skin reaction (e.g., blistering and peeling of the skin), inform your doctor or nurse immediately.
Angioedema (allergy in the skin that results in inflammation that occurs in the tissue under the skin surface) with respiratory tract obstruction (difficulty breathing) has been reported in some patients treated with solifenacin. If angioedema occurs, treatment should be discontinued immediately and appropriate treatment and/or measures should be taken.
Solifenacin may cause the following side effects:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Frequency not known (frequency cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below 30°C.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Solifenacin Normon
Tablet core: lactose monohydrate, hypromellose, corn starch, and magnesium stearate.
Tablet coating: Hypromellose, titanium dioxide (E171), lactose monohydrate, macrogol 6000, talc, and yellow iron oxide (E172).
Appearance of the product and package contents
Light yellow, round, biconvex film-coated tablets, engraved with "S5" on one side.
Solifenacin Normon is available in packages of 3, 5, 10, 20, 30, 50, 60, 90, 100, or 200 tablets.
Not all package sizes may be marketed.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON, S.A.
C/Ronda de Valdecarrizo, 6
28760 Tres Cantos, Madrid (Spain)
Date of the last revision of this package leaflet: February 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medication by scanning the QR code included in the package leaflet and packaging with your smartphone. You can also access this information at the following internet address
https://cima.aemps.es/cima/dochtml/p/83736/P_83736.html.
The average price of SOLIFENACIN NORMON 5 mg FILM-COATED TABLETS in October, 2025 is around 20.4 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SOLIFENACIN NORMON 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.